GET you labeled it as Non Disclosure of the Royalty type payment arrangement GTI has with Shenghou Medical LLC now know as K2 an entity owned by Faupel and Blumberg.
Also, I stated Faupel and Blumberg are being sued for engaging in unfair and deceptive trade practices in MA, and I stated as part of that is the allegations of numerous non disclosures by them to GIUL in seeking funding via a loan from GIUL.
Previously stated Shenghou Medical LLC now know as K2 did not have the expertise to full fill the terms of the original licensing agreement and I asked a question to be pondered on by GTI Shareholders why would GTI enter into what I my humble opinion my mere humble opinion was a SHAM transaction Licensing Agreement. Sham (noun) a thing that is not what it is purported to be; (adjective) bogus; false; (verb) falsely presented something as the truth;
So in my opinion, solely my opinion Faupel and Blumberg setup and entity to enter into a SHAM licensing agreement with GTI to strip out (a cash flow economic beneficial royalty type payment interest to themselves - where they in fact received monies from GTI which were paid over to Shenghou Medical, LLC now know a K2.
In my opinion solely in my opinion this sounds like self dealing benefiting Faupel and Blumberg at the expense of GTI Shareholders, I am in fact a shareholder of GTI. The only share holder who knows this and has all the facts and paper trail. You can label as you see fit. I would say the Shareholders have an civil action against GTI and others.
